Truveta has unveiled a groundbreaking clinical trials solution, offering sponsors real-time access to daily refreshed US health data. By speeding patient identification and enrollment, the platform promises to reduce delays in developing new therapies.
Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation
Key Takeaways:
- Truveta has launched a new clinical trials solution offering daily refreshed real-world data.
- The platform was developed in collaboration with leading US health system members.
- Real-time visibility helps sponsors identify eligible patients and sites as soon as they qualify.
- Michael Simonov, MD, underscores the urgency of accelerating study timelines.
- This solution refines eligibility criteria and delivers instant updates on study performance.
Launch of a New Solution
Truveta announced the debut of its clinical trials solution on January 27, 2026, unveiling a product designed to help trial sponsors design, optimize, and execute clinical studies. Leveraging what Truveta calls “the most complete, daily refreshed real-world data in the United States,” this platform promises to cut the lag time traditionally associated with clinical research.
Why Real-Time Data Matters
Daily updated information plays a crucial role in identifying eligible patients more efficiently. By tapping into medical records refreshed across Truveta’s partner health systems, sponsors can see when patients meet qualifying criteria. This capability cuts down waiting periods and boosts the pace of discoveries, underlining the growing role of real-world data in modern research.
Collaboration with Leading Health Systems
Truveta emphasizes that its new platform comes from close work with major US health system members. The partnership has produced a level of site-level visibility that allows sponsors to prioritize trial-ready locations and track performance more accurately. From shaping recruitment strategies to monitoring investigator activities, this collaboration aims to bring unprecedented speed and precision to clinical trials.
A Word from Truveta’s Leadership
“Every day matters when you are developing new therapies,” says Michael Simonov, MD, Senior Vice President of Product at Truveta. “With real-time data enabling sponsors to identify opportunities within days of patient encounters across our nationwide health system partners, Truveta’s new clinical trials offering brings a step-change in speed and intelligence to the entire clinical trial lifecycle.”
Refining Enrollment and Improving Outcomes
The core of this solution lies in refining complex eligibility criteria and ensuring that as soon as patients qualify, they can be identified and enrolled. Trial sponsors can reach clinicians caring for these patients quickly—a vital step in boosting trial participation. Truveta’s solution helps improve the entire clinical trial journey, spanning study design, enrollment, and real-time evidence generation.
By aligning powerful data with widespread health system collaboration, Truveta’s offering aims to shorten the distance between patient qualification and groundbreaking new therapies.